Top 12 Mistakes in Perinatal Psychiatry

September 15, 2020

Although they may have been the result of good intentions, these mistakes could adversely impact mother and baby.

Cytochrome P450: You've Come a Long Way

August 25, 2020

Two examples described here underscore the importance of understanding the cytochrome P450 (CYP) system

Topiramate in Bipolar Disorder and Comorbidities: The Myths and the Evidence

August 13, 2020

There are some off-label proposed uses for topiramate in comorbidities that are common in patients with bipolar disorder. What does the evidence say?

Minefields and Med-Checks: Getting to the Right Questions

August 06, 2020

Sometimes our best intentions lead us down the wrong road. By reconsidering a few seemingly harmless questions, this psychiatrist was able to make the most of his medication-check visits with his patients.

New Drug Indication for Patients With Depression Could Be Life-Changing

August 04, 2020

Taken with an oral antidepressant, esketamine is now approved to treat symptoms of MDD in patients with acute suicidal ideation or behaviors.

Key Concepts About Polypharmacy in Psychotic Disorders

August 03, 2020

Clinicians should keep in mind the risk-to-benefit ratio considerations before initiating polypharmacy, especially if they have patients with prescriptions inherited from several sources. Here: A summary of recommendations about the use of polypharmacy in psychotic disorders.

Perception of Adverse Drug Interactions

July 14, 2020

When is an adverse drug reaction actually a drug interaction? And vice versa? More in this video.

Special Issues for Patients With SUDs Undergoing Surgery

May 18, 2020

This innovative program at Massachusetts General Hospital addresses postoperative pain while preventing relapse in patients a history of opioid use disorder.

The Buzz on Long-Acting Injectable Antipsychotics

March 17, 2020

What are the benefits of using LAI antipsychotics? What are the major obstacles to adherence? Those questions and more in this podcast.

Pharmaceutical Company Makes the FDA’s Naughty List

March 06, 2020

After receiving complaints, the FDA’s Office of Prescription Drug Promotion rebukes the pharmaceutical company for misleading advertising.